Luis A Diaz Selected Research

Disease Progression

1/2023	Pembrolizumab for previously treated, microsatellite instability-high/mismatch repair-deficient advanced colorectal cancer: final analysis of KEYNOTE-164.
1/2023	Functionally distinct BMP1 isoforms show an opposite pattern of abundance in plasma from non-small cell lung cancer subjects and controls.
12/2020	Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.
1/2020	Mismatch Repair-Deficient Rectal Cancer and Resistance to Neoadjuvant Chemotherapy.
1/2020	Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study.
2/2016	Longer Course of Induction Chemotherapy Followed by Chemoradiation Favors Better Survival Outcomes for Patients With Locally Advanced Pancreatic Cancer.
10/2007	Serial assessment of human tumor burdens in mice by the analysis of circulating DNA.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luis A Diaz Research Topics

Disease

106	Neoplasms (Cancer) 01/2024 - 03/2004
35	Pemphigus (Pemphigus Vulgaris) 01/2022 - 05/2002
31	Colorectal Neoplasms (Colorectal Cancer) 03/2023 - 03/2004
18	Blister (Bulla) 10/2023 - 08/2002
17	Microsatellite Instability 03/2023 - 10/2016
16	Bullous Pemphigoid (Pemphigoid) 10/2023 - 10/2002
14	Skin Diseases (Skin Disease) 07/2023 - 05/2002
12	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 04/2005
11	Pemphigus and fogo selvagem 01/2018 - 08/2002
10	Adenocarcinoma 01/2023 - 07/2008
9	Melanoma (Melanoma, Malignant) 01/2024 - 04/2013
9	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 02/2012
8	Acantholysis 06/2015 - 06/2005
7	Disease Progression 01/2023 - 10/2007
6	Neoplasm Metastasis (Metastasis) 12/2019 - 03/2004
5	Carcinoma (Carcinomatosis) 01/2024 - 10/2010
5	Carcinogenesis 12/2018 - 08/2011
4	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2013
4	Turcot syndrome 01/2019 - 06/2015
3	Inflammation (Inflammations) 10/2023 - 11/2006
3	Fatigue 01/2022 - 01/2020
3	Leishmaniasis 01/2022 - 12/2004
3	Rectal Neoplasms (Rectal Cancer) 01/2022 - 01/2012
3	Infections 09/2020 - 10/2007
3	Colonic Neoplasms (Colon Cancer) 11/2017 - 06/2011
3	Glioma (Gliomas) 01/2014 - 07/2012
3	Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) 07/2013 - 10/2002
3	Brain Neoplasms (Brain Tumor) 04/2013 - 09/2008
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 01/2023
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 10/2023 - 01/2020
2	Leukemia 01/2023 - 08/2011
2	Virus Diseases (Viral Diseases) 01/2022 - 09/2008
2	COVID-19 11/2021 - 10/2020
2	Bites and Stings (Sting) 11/2021 - 12/2020
2	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2018
2	Endometrial Neoplasms (Endometrial Cancer) 01/2018 - 01/2013
2	Renal Cell Carcinoma (Grawitz Tumor) 10/2016 - 12/2011
2	Residual Neoplasm 01/2016 - 01/2013
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2014 - 03/2011
2	Lymphoma (Lymphomas) 04/2014 - 03/2011
2	Intellectual Disability (Idiocy) 04/2013 - 03/2011

Drug/Important Bio-Agent (IBA)

43	AutoantibodiesIBA 10/2023 - 05/2002
29	Immunoglobulin G (IgG)IBA 10/2023 - 10/2002
28	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 11/2005
23	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2009
22	Immune Checkpoint InhibitorsIBA 10/2023 - 09/2013
19	Proteins (Proteins, Gene)FDA Link 10/2023 - 10/2002
15	Desmoglein 1IBA 01/2022 - 08/2002
14	Cell-Free Nucleic AcidsIBA 01/2022 - 11/2005
14	AntibodiesIBA 01/2022 - 05/2002
11	pembrolizumabIBA 01/2024 - 06/2015
10	AntigensIBA 12/2020 - 01/2006
9	Circulating Tumor DNAIBA 01/2018 - 09/2008
5	Cetuximab (Erbitux)FDA Link 03/2023 - 04/2013
5	Gemcitabine FDA Link 01/2023 - 02/2012
5	Monoclonal AntibodiesIBA 01/2022 - 06/2013
5	Cadherins (E-Cadherin)IBA 01/2018 - 06/2005
5	DesmogleinsIBA 06/2010 - 11/2006
4	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 12/2012
4	Salivary Proteins and PeptidesIBA 01/2022 - 06/2010
4	p38 Mitogen-Activated Protein KinasesIBA 04/2011 - 11/2006
3	Immunoglobulin E (IgE)IBA 10/2023 - 04/2011
3	EpitopesIBA 07/2023 - 06/2003
3	Docetaxel (Taxotere)FDA Link 01/2023 - 02/2012
3	Carcinoembryonic AntigenIBA 01/2023 - 09/2009
3	Peptides (Polypeptides)IBA 01/2023 - 01/2009
3	NivolumabIBA 01/2022 - 11/2016
3	Calcibiotic Root Canal SealerIBA 11/2021 - 01/2019
3	Fluorouracil (Carac)FDA LinkGeneric 12/2020 - 03/2004
3	LigandsIBA 01/2019 - 01/2006
3	Glycoproteins (Glycoprotein)IBA 01/2015 - 12/2010
3	Immunoglobulin M (IgM)IBA 04/2011 - 10/2002
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 10/2023 - 04/2005
2	Immunoglobulin A (IgA)IBA 07/2023 - 01/2012
2	Bevacizumab (Avastin)FDA Link 03/2023 - 12/2020
2	Protein Isoforms (Isoforms)IBA 01/2023 - 12/2018
2	Capecitabine (Xeloda)FDA Link 01/2023 - 02/2012
2	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 12/2012
2	Alanine Transaminase (SGPT)IBA 01/2022 - 01/2020
2	Antineoplastic Agents (Antineoplastics)IBA 11/2021 - 10/2020
2	VemurafenibIBA 01/2021 - 06/2013
2	AutoantigensIBA 12/2020 - 03/2016
2	PlatinumIBA 11/2020 - 09/2015
2	Lipase (Acid Lipase)FDA Link 01/2020 - 10/2007
2	Rituximab (Mabthera)FDA Link 03/2019 - 08/2007
2	AllergensIBA 01/2019 - 06/2012
2	Complement System Proteins (Complement)IBA 01/2019 - 11/2006
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2018 - 12/2005
2	Desmosomal CadherinsIBA 01/2017 - 11/2006
2	IpilimumabIBA 11/2016 - 09/2013
2	ErbB Receptors (EGF Receptor)IBA 10/2015 - 06/2013
2	ChromatinIBA 09/2014 - 07/2012
2	Indicators and Reagents (Reagents)IBA 01/2014 - 12/2013
2	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2013 - 04/2013
2	Desmoglein 3IBA 11/2012 - 12/2008

Therapy/Procedure

47	Therapeutics 01/2023 - 10/2004
24	Drug Therapy (Chemotherapy) 01/2024 - 03/2004
16	Immunotherapy 04/2022 - 08/2014
3	Neoadjuvant Therapy 01/2022 - 07/2017
2	Chemoradiotherapy 01/2024 - 01/2012